Organigram Holdings Inc. (TSE:OGI – Get Free Report) hit a new 52-week low during mid-day trading on Monday after ATB Capital lowered their price target on the stock from C$9.00 to C$6.50. The company traded as low as C$1.94 and last traded at C$1.97, with a volume of 246681 shares changing hands. The stock had previously closed at C$2.04.
A number of other brokerages have also issued reports on OGI. Stifel Nicolaus dropped their price objective on shares of Organigram from C$1.50 to C$1.25 in a report on Thursday, April 13th. Canaccord Genuity Group dropped their price objective on shares of Organigram from C$9.00 to C$4.00 in a report on Monday. Canaccord Genuity Group lowered their price target on shares of Organigram from C$3.25 to C$2.25 in a report on Thursday, April 13th. Jefferies Financial Group lowered their price target on shares of Organigram from C$1.80 to C$1.50 in a report on Friday, April 21st. Finally, Haywood Securities lowered their price target on shares of Organigram from C$1.60 to C$1.25 in a report on Thursday, April 13th.
Organigram Trading Down 2.5 %
The company has a market cap of C$160.20 million, a price-to-earnings ratio of -16.58, a P/E/G ratio of 0.42 and a beta of 1.36. The company has a current ratio of 6.50, a quick ratio of 2.62 and a debt-to-equity ratio of 0.04. The firm’s 50-day moving average price is C$0.80 and its 200 day moving average price is C$0.92.
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates.
Further Reading
- Five stocks we like better than Organigram
- Is It Time To Take Another Bite Of Chewy, Inc?
- GreenPower Motor Company Shifts Into High Gear
- Is the Microsoft Deal Driving Applied Optoelectronics 300% Gain?
- Can Unity Software Sustain The Momentum?
- Nvidia Invested $50 million into This AI Drug Discovery Biotech
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.
